Glucagon Agonists

1 peptide with this mechanism of action

Retatrutide

Also: LY3437943, Triple G

An investigational triple agonist targeting GIP, GLP-1, and glucagon receptors. Phase 3 trials show potential for up to 24% body weight reduction, making it the most potent obesity treatment in development.

Glucagon AgonistsWeight LossMetabolic